Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
14.58M 8.05M 7.88M 21.57M 31.16M
Short-Term Investments
69.53M n/a 101.03M 100.96M 100.9M
Long-Term Investments
n/a 88.32M n/a n/a n/a
Other Long-Term Assets
18.73M -70.64M 9.32M 520.73K 141.2K
Receivables
99.7K 66.05K 71.42K 102.59K 103.23K
Inventory
n/a n/a n/a n/a n/a
Other Current Assets
2.36M 91.21M 2.85M 2.12M 1.72M
Total Current Assets
86.58M 99.33M 111.83M 124.76M 133.88M
Property-Plant & Equipment
5.46M 3.94M 4.19M 6.19M 3.13M
Goodwill & Intangibles
3.5M n/a 7.32M 7.32M 7.32M
Total Long-Term Assets
27.69M 21.63M 20.82M 14.03M 10.59M
Total Assets
114.27M 120.96M 132.66M 138.79M 144.47M
Account Payables
2.23M 922.78K 1.07M 1.18M 792.54K
Deferred Revenue
n/a 35K 147.5K 100K 93.53K
Short-Term Debt
664.62K 610.92K 564.29K 404.64K 395.68K
Other Current Liabilities
2.42M 3.15M 1.51M 1.67M 1.76M
Total Current Liabilities
5.31M 4.72M 3.29M 3.35M 3.05M
Long-Term Debt
1.4M 1.06M 1.5M 1.26M 1.36M
Other Long-Term Liabilities
2.6M 2.9M 3.4M 3.11M 3M
Total Long-Term Liabilities
4.25M 4.21M 5.5M 4.97M 4.96M
Total Liabilities
9.57M 8.93M 8.79M 8.32M 8.01M
Total Debt
2.06M 1.67M 2.06M 1.66M 1.76M
Common Stock
5.12K 5.05K 5.03K 5.03K 5.03K
Retained Earnings
-173.84M -165.72M -152.16M -144.72M -138.18M
Comprehensive Income
-123.21K -67.94K -52.55K -121.13K -147.79K
Shareholders Equity
105.84M 112.03M 124.89M 131.39M 137.3M
Total Investments
69.53M 88.32M 101.03M 100.96M 100.9M